Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 8/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | C1R | P00736 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TRIM58 | Q8NG06 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4117968 | 0.80 | ELANE (1.00) | ELANENPC1RAB9AC1RALDH1A1 | |
| SCHEMBL29444197 | 0.79 | ELANE (1.00) | ELANENPC1RAB9A | |
| SCHEMBL146072 | 0.79 | ELANE (1.00) | ELANENPC1RAB9A | |
| SCHEMBL12352090 | 0.78 | ELANE (1.00) | ELANEGAAKCNA3NPC1RAB9A | |
| SCHEMBL12597036 | 0.78 | GAA (0.75) | ELANEGAAL3MBTL1NPC1RAB9A | |
| SCHEMBL5754010 | 0.78 | ELANE (0.55) | ELANENPC1RAB9AC1RALDH1A1 | |
| SCHEMBL12352004 | 0.77 | ELANE (0.70) | ELANERAB9A | |
| SCHEMBL3539033 | 0.77 | ELANE (0.70) | ELANEKCNA3C1RALDH1A1 | |
| SCHEMBL4123057 | 0.77 | ELANE (0.70) | ELANEALDH1A1 | |
| SCHEMBL31000399 | 0.77 | ELANE (0.70) | ELANEL3MBTL1C1RALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8541488-B2 | Formed resin article and polymer film | FUJIFILM CORPORATION (JP) | 2013-09-24 | — | — | US | disclosed |
| US-8541488-B2 | Formed resin article and polymer film | FUJIFILM CORPORATION (JP) | 2013-09-24 | — | — | US | disclosed |
| US-20110186791-A1 | ULTRAVIOLET ABSORBENT COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110186791-A1 | ULTRAVIOLET ABSORBENT COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110092619-A1 | FORMED RESIN ARTICLE AND POLYMER FILM | FUJIFILM CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-20110092619-A1 | FORMED RESIN ARTICLE AND POLYMER FILM | FUJIFILM CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-7897761-B2 | Heterocyclic compound | FUJIFILM CORPORATION (JP) | 2011-03-01 | — | — | US | disclosed |
| US-7897761-B2 | Heterocyclic compound | FUJIFILM CORPORATION (JP) | 2011-03-01 | — | — | US | disclosed |
| US-20110024701-A1 | Ultraviolet Absorbent Composition | FUJIFILM CORPORATION (JP) | 2011-02-03 | — | — | US | disclosed |
| US-20110024701-A1 | Ultraviolet Absorbent Composition | FUJIFILM CORPORATION (JP) | 2011-02-03 | — | — | US | disclosed |
| EP-2270076-A1 | RESIN MOLDED PRODUCT AND POLYMER FILM | FUJIFILM Corporation (JP) | 2011-01-05 | — | — | EP | disclosed |
| EP-2270113-A1 | ULTRAVIOLET ABSORBENT COMPOSITIONS | FUJIFILM Corporation (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-20100004439-A1 | Heterocyclic Compound | FUJIFLM CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
| US-20100004439-A1 | Heterocyclic Compound | FUJIFLM CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
| US-20090239982-A1 | Ultraviolet Absorbent and Heterocyclic Compound | FUJIFILM CORPORATION (JP) | 2009-09-24 | — | — | US | disclosed |
| US-20090239982-A1 | Ultraviolet Absorbent and Heterocyclic Compound | FUJIFILM CORPORATION (JP) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239982-A1 | Ultraviolet Absorbent and Heterocyclic Compound | CYP2A6, CYP2B6, XPO6 | ELANE 1479/4885GAA 2950/4885L3MBTL1 2124/4885 |
| US-20100004439-A1 | Heterocyclic Compound | PTGER1, CYP1A1, ALOX12 | ELANE 1343/4885GAA 4088/4885L3MBTL1 4235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.